Related Experiment Video

Updated: Sep 23, 2026

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
06:52

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

53.5K

Decreased physical activity in lupus patients, an analysis of biometric data from the all of us database

Evelyn F Fagan1,2, Christopher Reagen3, Joseph T McGrath4,2

  • 1Mercer University School of Medicine, Savannah, GA, USA.

Archives of Dermatological Research
|April 25, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Biometric dataCutaneous lupus erythematosusExerciseLupus erythematosusPhysical activitySystemic lupus erythematosus

More Related Videos

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.8K
Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
07:44

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass

Published on: July 14, 2023

1.0K

Related Experiment Videos

Last Updated: Sep 23, 2026

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
06:52

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

53.5K
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.8K
Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
07:44

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass

Published on: July 14, 2023

1.0K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Articles linked to this work by shared authors, journal, and citation graph.

Trends in Pediatric Representation Within Skin of Color Dermatology Literature: A Decade-Long Analysis.

Pediatric dermatology·2026

Retrospective Study of Severe Atopic Disease in Young Children (0-5 Years) Managed with Dupilumab Highlights Significant Comorbidities.

Children (Basel, Switzerland)·2025

Changes in Hepatitis B Core Antigen and Hepatitis B Surface Antigen Expression Following Antiviral Therapy and Their Role in Outcome of Patients With Chronic Hepatitis B.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2025

Invisible Bias in GPT-4o-mini: Detecting Disparities in AI-Generated Patient Messaging.

Journal of medical systems·2025

Antigen-Fc fusion therapy reduces severity of a model of pemphigus vulgaris without systemic immunosuppression.

Science translational medicine·2025

Analysis of current dermatopathology training across U.S. residency programs.

Archives of dermatological research·2025

Transgender Individuals' Perspectives on Teledermatology-Based Acne Research.

Archives of dermatological research·2026

Nicotinamide for secondary keratinocyte carcinoma prevention in solid organ transplant recipients.

Archives of dermatological research·2025

Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review.

Archives of dermatological research·2025

Wells syndrome: emerging triggers and treatments- an updated systematic review.

Archives of dermatological research·2025

Comparative study between intralesional acyclovir versus intralesional 5-flurouracil in treatment of recalcitrant warts.

Archives of dermatological research·2025

Assessment of efficacy of carboxytherapy in reducing thickness of abdominal subcutaneous fat through clinical and ultrasonographical studies: a randomized 2-split clinical trial.

Archives of dermatological research·2025
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us